BIOMAP
Biomarkers in Atopic Dermatitis and Psoriasis
- Description
The main aim of the IMI project BIOMAP is to improve the lives of patients affected by the two most common inflammatory skin conditions. Addressing key unmet needs in treating atopic dermatitis and psoriasis, the five-year project will have a broad impact on disease understanding, patient care and future therapies. The team comprises 27 academic and seven pharma partners as well as six patient organisations.
- Coordinator
- Programme
- Horizon 2020 & sub-programmes
- Duration
- 72 months (April 2019 - March 2025)
- Project funding
- € 21,953,308.79
- Project partners
- 34
- Project website
- http://www.biomap-imi.eu
